Skip to content
About Us
Menu Toggle
Leadership Team
Who We Are
What We Do
Media
Funding Opportunity Areas
Menu Toggle
Life Sciences
Menu Toggle
BARDA
ARPA-H Funding
NIAID Funding
JPEO-CBRND
DoD Agencies & Offices
Menu Toggle
DARPA Funding
DTRA Funding
Autonomous Technology
Menu Toggle
Defense and Security Innovation
Menu Toggle
DARPA Funding
DIU Funding
JAIC
Branch Programs
Artificial Intelligence R&D
Emerging Technologies & Infrastructure
Cybersecurity & Digital Defense
Unmanned Systems & Autonomous Platforms
Energy
Menu Toggle
ARPA-E
EERE
Infrastructure Act
Federal Contract Termination Support
DFC Funding
Not Sure?
Insights
Careers
Main Menu
Home
About Us
Menu Toggle
Overview
Team
Media
What We Do
Menu Toggle
DOD Funding
Menu Toggle
DARPA Funding
DIU Funding
JPEO-CBRND
DTRA Funding
DPA Title III Funding
Life Sciences
Menu Toggle
BARDA Funding
BARDA
NIAID Funding
ARPA-H Funding
CHIPS Act Funding
Not sure?
Insights
Careers
Menu Toggle
Why EverGlade
Search Jobs
EverGlade Consulting Helps Sabin Vaccine Institute Secure up to $214 Million in BARDA Funding to Develop and Procure Ebola Sudan and Marburg Vaccines
Featured In:
NY Daily News
US News
Time
AP
Chicago Tribune
The Denver Post
SF Gate
Click here to read the full article
EverGlade Consulting Helps GeoVax Secure up to $45 Million in BARDA Funding
Read More
ARPA-H Announces Mission Office-Specific Funding Opportunities
Read More
ARPA-H Seeks Revolutionary Solutions for Precision Cancer Therapy Through ADAPT Program
Read More
Scroll to Top
